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SUMMARY
 
It has been reported that bacterial superantigens induce interleukin (IL)-12 dependent expression of
the cutaneous lymphocyte associated antigen (CLA) and that this may be relevant to the association
between certain skin diseases and infections including psoriasis and streptococcal tonsillitis. We have
confirmed that the streptococcal pyrogenic superantigen C (SpeC) increases CLA expression by both
CD4
 
+
 
 and CD8
 
+
 
 T cells when PBMCs are incubated in medium enriched with fetal calf serum (FCS).
However, such an increase could not be induced in medium enriched with human serum (HS) even
when recombinant IL-12 was added to the PBMCs cultures. Strikingly, CD4
 
+
 
 T cells incubated with
SpeC in HS showed a marked reduction in CLA expression, which was not due to apoptosis. In contrast,
SpeC did induce T cell proliferation and expression of CD25, CD54 and CD103 in the presence of HS
indicating that the absence of SpeC induced CLA expression in HS was not due to SpeC inhibitors.
Although addition of low amounts of lipopolysaccharide endotoxin (LPS) caused a highly significant
increase in CLA expression in the absence of SpeC in cultures enriched with HS, a combination of LPS
and SpeC did not increase CLA expression beyond that induced by LPS alone. The superantigen-
induced CLA expression in FCS was partially inhibited by anti-IL-12 but not by anti-IL-18 or antibodies
to transforming growth factor (TGF)-
 
b
 
. It is concluded that IL-12 alone can not increase CLA expres-
sion but requires the help of other factor(s) present in FCS but not in HS. Although LPS can induce
CLA expression it does not seem to be the factor that interacts with IL-12 to induce superantigen-
mediated CLA expression in cultures enriched with FCS.
 
Keywords
 
superantigen CLA induction interleukin-12
 
INTRODUCTION
 
Streptococcal pyrogenic exotoxins have been shown to act as
superantigens that activate T lymphocytes expressing certain T
cell receptor V
 
b
 
 regions [1]. These may include potentially
autoreactive T cells and superantigens have therefore been
implicated in the aetiology of autoimmune diseases [2]. Cutane-
ous lymphocyte associated antigen (CLA) is a surface glycopro-
tein epitope that binds to E-selectin on vascular endothelium in
skin [3] and is expressed by a subpopulation of memory-type T
cells. Over 80% of T cells that infiltrate the skin express CLA
while it is normally detected on less than 20% of peripheral
blood T lymphocytes suggesting that CLA may play a major role
in the homing of T cells to the skin [4–6]. Bacterial superantigens
have been reported to induce IL-12 mediated expression of a
CLA by lymphocytes and it has been argued that this may con-
tribute to the development of T cell mediated skin diseases
including psoriasis [7]. In contrast, superantigen-mediated induc-
tion of the mucosal integrin CD103 (
 
a
 
E
 
b
 
7) has to our knowl-
edge not been reported.
IL-12 is a potent inflammatory cytokine mainly produced by
accessory cells and has been shown to be a powerful inducer of
IFN-
 
g
 
 production and Th1 responses [8]. It is also the only known
physiological inducer of CLA expression [7,9]. The intercellular
adhesion molecule I (ICAM-1, CD54) is a ligand for the leucocyte
function associated (LFA) integrin and its importance for binding
of leucocytes to vascular endothelium and other cells is well rec-
ognized [10]. However, ICAM-1 can also be expressed by B- and
T lymphocytes [6,11].
Using medium supplemented with human serum (HS) we
have not been able to induce CLA expression by human T cells
with streptococcal superantigens. As previously published studies
of such expression have all been performed in medium enriched
with fetal calf serum (FCS) [7,9,12] we decided to compare the
 IL-12 and induction of CLA
 
431
 
© 2003 Blackwell Publishing Ltd, 
 
Clinical and Experimental Immunology
 
, 
 
132
 
:430–435
 
effects of superantigens on the induction of CLA by T cells incu-
bated in medium supplemented either with FCS or HS. Our find-
ings indicate that IL-12 requires at least one cofactor for inducing
CLA expression by human T cells and that this factor is unlikely
to be endotoxin.
 
MATERIALS AND METHODS
 
Study population
 
Healthy individuals (
 
n
 
 
 
=
 
 33) with no history of skin disorders or
immunological diseases were included in the study. The study was
approved by the Landspitali Bioethics Committee.
 
Reagents
 
Monoclonal antibodies to the following surface antigens that
were fluorescein isothiocyanate (FITC), phycoerythrin (PE) and
peridinin chlorophyll protein (PerCP) conjugated were used:
CD4-PerCP (SK3), CD8-PerCP (SK1), CD25-PE (2A3), CD54-
PE (LB-2), CD103-PE (Ber-ACT8), and CLA-FITC (HECA-
452). Controls used were FITC or PE-conjugated mouse IgG1/
IgG2 or rat IgM (Becton Dickinson, Heidelberg, Germany).
Annexin V-FITC and propidium iodide were used for determin-
ing apoptosis (R & D Systems Europe Ltd, Oxon, UK).
Recombinant IL-12 and neutralizing anti-IL-12 (MAB219),
anti-IL-18 (MAB318) and anti-TGF-
 
b
 
1,2,3 (MAB1845) antibod-
ies were purchased from R & D. LPS was purchased from Sigma
(Sigma-Aldrich, Vallensbæk Strand, Denmark).
 
Isolation and stimulation of peripheral mononuclear 
blood lymphocytes
 
Peripheral blood mononuclear cells (PBMC) were isolated from
heparinized blood by density gradient. The cells were washed
twice and resuspended in RPMI 1640 (Gibco BRL, Life Technol-
ogies, Paisley, UK) supplemented with 2 m
 
M
 
 glutamine (Gibco),
100 U/ml penicillin/100 
 
m
 
g streptomycin (Gibco) with either 10%
heat-inactivated human AB serum (HS) or 10% heat-inactivated
fetal calf serum (FCS/Gibco). The FCS contained less than 10
units/ml of endotoxin. Streptococcus pyrogenic exotoxin C
(SpeC) was purchased from Toxin Technologies (Saratoga, Cali-
fornia, USA). PBMCs (2 
 
¥
 
 10
 
5
 
/well) were cultured in u-bottomed
96-well microtitre plates (Nunc, Life Technologies) with superan-
tigen SpeC (100 ng/ml) or LPS (5, 10, 20 ng/ml) for 4 days. This
concentration of the SpeC and the incubation time had previously
been shown to give an optimal induction of CLA while a marked
apoptosis is observed when the incubation time is extended
beyond 5 days (unpublished results). In some experiments the
PBMCs were incubated with different concentrations (0·2–5 ng/
ml) of recombinant IL-12 or with different concentrations of neu-
tralizing anti-IL-12, anti-IL-18 or anti-TGF-
 
b
 
1,2,3 antibodies.
Proliferation was determined by pulsing SpeC stimulated cultures
with tritiated thymidine (1 
 
m
 
Ci/well; Amersham International,
Aylesbury, UK) for 16 h before the cells were harvested after
4 days. The thymidine incorporation was measured by liquid scin-
tillation spectroscopy,
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Fig. 1.
 
PBMCs from 10 individuals were incubated for 2 days in medium
containing 10% FCS but no superantigen. (a) A significant increase was
observed in CLA expression by the CD8
 
+
 
 T cells and this increase was
largely inhibited with antibodies against IL-12. (b) FCS did not influence
CLA expression of CD4
 
+
 
 T cells.
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Statistical analysis
 
Statistical significance of differences was determined by a paired
 
t
 
-test, as all the data had a normal distribution. 
 
P
 
-values below
0·05 were considered to be statistically significant
 
RESULTS
 
Increased CLA expression by T cells was observed after 
superantigen stimulation in FCS but not in HS
 
When PBMCs from 10 individuals were incubated in 10% FCS in
the absence of superantigen, a significant increase in the fre-
quency of CLA 
 
+
 
 CD8
 
+
 
 T cells was observed within 2 days and
this increase could largely be inhibited by IL-12 antibodies
(Fig. 1a). However, CLA expression by CD4
 
+
 
 T cells did not
increase (Fig. 1b) and incubation in HS for up to 4 days did not
significantly influence the CLA expression (Fig. 2).
When PBMCs from 33 healthy individuals were incubated
with SpeC for 4 days in medium containing 10% FCS, a highly sig-
nificant increase was observed in CLA expression by both CD4
 
+
 
and CD8
 
+
 
 T cells (Fig. 2a). However, no such increases were
observed for T cells that were incubated in HS. On the contrary
there was a striking reduction in the frequency of CLA 
 
+
 
 CD4
 
+
 
 T
cells but the frequency of CLA 
 
+
 
 CD8
 
+
 
 T cells remained
unchanged (Fig. 2a). The difference in CLA expression by T cells
cultured in FCS or HS was not due to higher rate of apoptosis in
 
Triple immunofluorescence staining and flow cytometry
 
On day 0 and after 2 and 4 days of incubation the lymphocytes
were triple-stained with the FITC-, PE- and PerCP conjugated
monoclonal antibodies for 30 min on ice. The cells were then
washed twice in PBS before fixation in 0·5% formalin. Stained
lymphocytes were immediately submitted to flow cytometric anal-
ysis using a FACScan (Becton Dickinson). The analysis on day 0
(d0) was performed using a light scatter including only small lym-
phocytes, whereas activated cultured populations were analysed
with the light scatter set on both small lymphocytes and large T
cell population. Nonspecific binding was never more than 1%.
Cells expressing low amounts of CD4
 
+
 
 and CD8
 
+
 
 T cells were
excluded to avoid small monocytes. Apoptosis was determined by
flow cytometry analysis after staining with Annexin V and pro-
pidium iodide.
 
ELISA for detection of SpeC antibodies
 
To determine whether HS contained a significant amount of anti-
bodies against SpeC, microwell plates were coated with different
concentrations of SpeC (1–5 
 
m
 
g/ml), incubated for 2 h with serial
dilutions of the HS or FCS, followed by 2 h with alkaline-
phosphatase conjugated anti-human IgG (Sigma) and finally
developed with p-Nitrophenyl Phosphate Disodium (Sigma)
1 mg/ml in diethanolamine-HCl buffer (pH 
 
=
 
 9·8). Optical density
was read at 405 nm.
 
Fig. 2.
 
(a) PBMCs from 33 individuals were cultured for 4 days in HS or FCS with or without SpeC. An increase in CLA expression was
only observed in cultures enriched with FCS. Note that CD8
 
+
 
 T cells showed a significant increase in CLA expression after 4 days incubation
in FCS without superantigen. SpeC stimulation in HS caused a marked decrease in CLA expression by CD4
 
+
 
 T cells while no change was
observed in CD8
 
+
 
 T cells. (b) FACS histograms showing changes in CLA expression by T cells from 8 representative individuals, incubated
with and without SpeC in the presence of HS or FCS. The 
 
X
 
-axis shows the intensity of CLA expression and 
 
Y
 
-axis the T cell counts.
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the HS nor to SpeC antibodies, as determined by a sensitive
ELISA system (data not shown).
 
Addition of LPS but not IL-12 increased CLA expression by the 
T cells in the absence of SpeC
 
Addition of IL-12 (0·2, 2·0 or 5·0 ng/ml) to PBMCs from 12 indi-
viduals, cultured for 4 days in medium enriched with HS, did not
increase CLA expression by the T cells regardless of the IL-12
concentration (Fig. 3a) and this applied both to CD4
 
+
 
 and CD8
 
+
 
T cells (data not shown). However, addition of LPS (10 ng/ml)
caused about 50% increase in CLA expression (
 
P
 
 
 
=
 
 0·003) but no
further increase was observed when PBMCs in HS were exposed
to a combination of SpeC and IL-12, SpeC and LPS or to SpeC,
IL-12 and LPS (Fig. 3a). Furthermore, a combination of IL-12 and
LPS did not induce more CLA expression than LPS alone neither
in HS nor FCS (data not shown).
Addition of IL-12 did not augment the spontaneous increase
in CLA expression that was observed in cultures containing FCS
without superantigen and LPS induced only a borderline increase
in the absence of superantigen (Fig. 3b). However, addition of
LPS or IL-12 to SpeC stimulated cultures induced a modest
increase in CLA expression compared to cultures that were only
incubated with SpeC but no further increase in CLA expression
was observed in cultures incubated with a combination of LPS,
SpeC and IL-12 (Fig. 3b).
The SpeC induced increase in CLA expression by T cells
exposed to FCS was only partially inhibited by anti-IL-12 even at
the highest concentration (Fig. 4) while neutralizing monoclonal
antibodies to IL-18 or TGF-
 
b
 
 did not have any effect (data not
shown).
 
SpeC-induced lymphocyte proliferation and expression 
of CD25, CD54 and CD103 by T cells cultured in 
HS-enriched medium
 
Preliminary experiments showed that SpeC could, in addition to
lymphocyte proliferation, also induce the expression of CD25,
CD54 and CD103 by T cells cultured in medium enriched with
FCS. In order to assess the possibility that human serum might
contain inhibitors to SpeC, including antibodies, PBMCs from
15 individuals were incubated with and without SpeC in
medium containing HS or FCS. As shown in Fig. 5, SpeC-
induced lymphocyte proliferation and expression of CD54 was
very similar in cultures enriched with HS or FCS. A highly sig-
nificant SpeC-induced increase was also observed in the expres-
sion of CD25 and CD103 by T cells cultured in medium
containing HS (
 
P
 
 
 
<
 
 0·001), although these responses were much
stronger in cultures containing FCS (Fig. 5). The induction of
CD103 could be inhibited by anti-TGF-
 
b
 
 antibodies (data not
shown).
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Fig. 3.
 
PBMSc from 12 individuals were incubated for 4 days with various
components. (a) No increase in CLA expression was detected when up to
5 ng/ml of IL-12 was added to PBMC cultured in HS while addition of LPS
caused about 50% increase in CLA expression by the T cells. No further
increase was observed when the T cells were exposed to a combination of
LPS and SpeC, nor to a combination of IL-12, SpeC and LPS. (b) LPS
caused only a borderline increase in CLA expression by T cells cultured
in the presence of FCS with or without SpeC. Addition of IL-12 did not
increase CLA expression above that induced by FCS alone while the
addition of LPS or a combination of SpeC and LPS or SpeC and IL-12
induced a moderate increase in CLA expression.
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Fig. 5.
 
There was no difference in SpeC-induced proliferation or expression of CD54 by T cells after 4 day incubation in HS or FCS. The
differences between the expression of CD25 and CD103 in unstimulated cultures 
 
versus
 
 SpeC-stimulated HS cultures were highly significant
(
 
P
 
 
 
<
 
 0·001), although the SpeC-induced stimulation was much stronger in FCS for both these parameters. The columns represent counts
per minute (cpm) or percentages of T cells expressing each marker after subtraction of the values observed for unstimulated cultures.
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DISCUSSION
 
Previous reports have shown that bacterial superantigens can be
potent inducers of CLA expression by human T cells cultured
in medium enriched by FCS, and it was concluded that this was
mainly due to superantigen mediated production of IL-12 by
macrophages [7]. Increased expression of CLA has also been
observed when T cells are stimulated with antibodies including
anti-CD3, in the presence of FCS and exogenous IL-12
[9,13,14].
Sofar IL-12 is the only physiological component known to
increase CLA expression, but the mechanism of this activity
remains to be elucidated. Our findings indicate that superantigen-
induced up-regulation of CLA does not only involve the induc-
tion of IL-12 production as no increase in CLA expression is
observed when PBMCs are cultured with superantigen in medium
containing HS, even when large amounts of IL-12 are added. Fur-
thermore, SpeC was equally active in stimulating T cell prolifer-
ation and the expression of CD54 regardless of whether the
PBMCs are incubated in medium enriched with HS or FCS. The
failure of superantigen to induce CLA in the presence of HS is
therefore unlikely to be due to insufficient IL-12 production or
SpeC inhibitors, including antibodies. Our findings therefore indi-
cate that IL-12 alone can not induce CLA expression but requires
some other factor(s) that are present in FCS but not HS. How-
ever, such cofactor(s) are not essential for superantigen induction
of T cell proliferation nor expression of CD25, CD54 or CD103,
although the expression of CD25 and CD103 may to some extend
require cofactor(s) present in FCS (Fig. 5).
IL-12 is a universal and nontissue specific cytokine that is not
only produced by macrophages but also by a variety of other cells
[15–17]. Therefore, if IL-12 alone could increase CLA expression
by leucocytes, inflammatory processes in any tissue of the body
should give rise to increased numbers of leucocytes expressing
this adhesion molecule that is selective for the skin, a scenario
which conflicts with some recent observations indicating that
 
Fig. 4.
 
SpeC induced CLA expression was only partially inhibited by neu-
tralizing IL-12 antibodies. FCS exposed PBMCs were stimulated with
SpeC and incubated with different concentrations of anti-IL-12 antibodies
(
 
m
 
g/ml in brackets).
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inflammatory processes tend to induce tissue-specific homing
receptors on memory lymphocytes [5,18–21].
Addition of low concentrations of LPS did induce a significant
increase in the expression of CLA by T cells cultured in medium
enriched by HS, and this has not been reported before. It is
unlikely however, that LPS contamination of FCS explains the
striking difference between the HS and FCS in promoting super-
antigen induction of CLA as the addition of both IL-12 and LPS
to HS did not enhance CLA expression beyond that induced by
LPS alone. Furthermore, IL-12-dependent CLA expression was
only marginally increased by LPS, the increased CLA expression
by CD8
 
+
 
 T cells cultured in FCS without superantigen could
largely be inhibited by anti-IL-12 antibodies, and LPS had a very
modest effect on the superantigen-mediated induction of CLA
that takes place in FCS.
It is reasonable to assume that FCS may contain a variety
of growth factors and cytokines that are present in low concen-
trations or not at all in serum from adult humans. However, we
are not aware of any comparative studies in this respect. The
failure to induce CLA expression with superantigens in the
absence of FCS does in our view not exclude the possibility
that such an induction can take place when skin or tonsils are
infected by bacterial pathogens that produce superantigens.
Inflammatory processes in these tissues might give rise to fac-
tors that interact with IL-12 to induce CLA expression and we
are currently studying this possibility and the factors that may
be involved.
In conclusion this study demonstrated that IL-12 requires
some as yet unidentified cofactor(s) for enhancing the expression
of the skin-specific adhesion epitope CLA.
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